SEARCH

SEARCH BY CITATION

References

  • Baumann U, King M, App EM, Tai S, König A, Fischer JJ, Zimmermann T, Sextro W & von der Hardt H (2004) Long term azithromycin therapy in cystic fibrosis patients: a study on drug levels and sputum properties. Can Respir J 11: 151155.
  • Blasi F, Cazzola M, Tarsia P, Cosentini R, Aliberti S, Santus P & Allegra L (2005) Azithromycin and lower respiratory tract infections. Expert Opin Pharmacother 6: 23352351.
  • Campodónico VL, Gadjeva M, Paradis-Bleau C, Uluer A & Pier GB (2008) Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. Trends Mol Med 14: 120133.
  • Carfartan G, Gerardin P, Turck D & Husson MO (2004) Effect of subinhibitory concentrations of azithromycin on adherence of Pseudomonas aeruginosa to bronchial mucins collected from cystic fibrosis patients. J Antimicrob Chemother 53: 686688.
  • Chmiel JF, Berger M & Konstan MW (2002) The role of inflammation in the pathophysiology of CF lung disease. Clin Rev Allergy Immunol 23: 527.
  • Cohen TS & Prince A (2012) Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med 18: 509519.
  • Cruz AC, Neves BC, Higa LY, Folescu T, Marques EA & Milagres LG (2012) Type III apparatus of Pseudomonas aeruginosa as a tool to diagnose pulmonary infection in cystic fibrosis patients. APMIS 120: 622627.
  • Dacheux D, Toussaint B, Richard M, Brochier G, Croize J & Attree I (2000) Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils. Infect Immun 68: 29162924.
  • Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW & Greenberg EP (1998) The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280: 295298.
  • de la Fuente-Núñez C, Reffuveille F, Fernández L & Hancock RE (2013) Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr Opin Microbiol 16: 580589.
  • Favre-Bonté S, Köhler T & Van Delden C (2003) Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin. J Antimicrob Chemother 52: 598604.
  • Feola DJ, Garvy BA, Cory TJ, Birket SE, Hoy H, Hayes DJ & Murphy BS (2010) Azithromycin alters macrophage phenotype and pulmonary compartmentalization during lung infection with Pseudomonas. Antimicrob Agents Chemother 54: 24372447.
  • Fujitani S, Sun HY, Yu VL & Weingarten JA (2011) Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source. Chest 139: 909919.
  • Galle M, Jin S, Bogaert P, Haegman M, Vandenabeele P & Beyaert R (2012) The Pseudomonas aeruginosa type III secretion system has an exotoxin S/T/Y independent pathogenic role during acute lung infection. PLoS ONE 7: e41547.
  • Halldorsson S, Gudjonsson T, Gottfredsson M, Singh PK, Gudmundsson GH & Baldursson O (2010) Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 42: 6268.
  • Hauser AR (2009) The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol 7: 654665.
  • Hoffmann N, Lee B, Hentzer M, Rasmussen TB, Song Z, Johansen HK, Givskov M & Høiby N (2007) Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. Antimicrob Agents Chemother 51: 36773687.
  • Jacobs MA, Alwood A, Thaipisuttikul I et al. (2003) Comprehensive transposon mutant library of Pseudomonas aeruginosa. P Natl Acad Sci USA 100: 1433914344.
  • Köhler T, Perron GG, Buckling A & van Delden C (2010) Quorum sensing inhibition selects for virulence and cooperation in Pseudomonas aeruginosa. PLoS Pathog 6: e1000883.
  • Larrosa M, Truchado P, Espín JC, Tomás-Barberán FA, Allende A & García-Conesa MT (2012) Evaluation of Pseudomonas aeruginosa (PAO1) adhesion to human alveolar epithelial cells A549 using SYTO 9 dye. Mol Cell Probes 26: 121126.
  • López-Cortés LF, Cruz-Ruiz M, Gómez-Mateos J, Viciana-Fernandez P, Martinez-Marcos FJ & Pachón J (1995) Interleukin-8 in cerebrospinal fluid from patients with meningitis of different etiologies: its possible role as neutrophil chemotactic factor. J Infect Dis 172: 581584.
  • Mulet X, Maciá MD, Mena A, Juan C, Pérez JL & Oliver A (2009) Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants. Antimicrob Agents Chemother 53: 15521560.
  • Nalca Y, Jänsch L, Bredenbruch F, Geffers R, Buer J & Häussler S (2006) Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob Agents Chemother 50: 16801688.
  • Plotkowski MC, de Bentzmann S, Pereira SH, Zahm JM, Bajolet-Laudinat O, Roger P & Puchelle E (1999) Pseudomonas aeruginosa internalization by human epithelial respiratory cells depends on cell differentiation, polarity, and junctional complex integrity. Am J Respir Cell Mol Biol 20: 880890.
  • Roy-Burman A, Savel RH, Racine S, Swanson BL, Revadigar NS, Fujimoto J, Sawa T, Frank DW & Wiener-Kronish JP (2001) Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis 183: 17671774.
  • Saiman L, Anstead M, Mayer-Hamblett N et al. (2010) “Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 303: 17071715.
  • Saiman L, Mayer-Hamblett N, Anstead M et al. (2012) Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa. Pediatr Pulmonol 47: 641648.
  • Tabary O, Zahm JM, Hinnrasky J, Couetil JP, Cornillet P, Guenounou M, Gaillard D, Puchelle E & Jacquot J (1998) Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am J Pathol 153: 921930.
  • Terheggen-Lagro SW, Rijkers GT & van der Ent CK (2005) The role of airway epithelium and blood neutrophils in the inflammatory response in cystic fibrosis. J Cyst Fibros 4(suppl 2): 1523.
  • Verhaeghe C, Delbecque K, de Leval L, Oury C & Bours V (2007) Early inflammation in the airways of a cystic fibrosis foetus. J Cyst Fibros 6: 304308.
  • Vranes J (2000) Effect of subminimal inhibitory concentrations of azithromycin on adherence of Pseudomonas aeruginosa to polystyrene. J Chemother 12: 280285.
  • Wagner T, Soong G, Sokol S, Saiman L & Prince A (2005) Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients. Chest 128: 912919.
  • Wang Q, Sun FJ, Liu Y, Xiong LR, Xie LL & Xia PY (2010) Enhancement of biofilm formation by subinhibitory concentrations of macrolides in icaADBC-positive and -negative clinical isolates of Staphylococcus epidermidis. Antimicrob Agents Chemother 54: 27072711.
  • Wozniak DJ & Keyser R (2004) Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest 125: 62S69S; quiz 69S.
  • Wright EA, Fothergill JL, Paterson S, Brockhurst MA & Winstanley C (2013) Sub-inhibitory concentrations of some antibiotics can drive diversification of Pseudomonas aeruginosa populations in artificial sputum medium. BMC Microbiol 13: 170.
  • Yousef AA & Jaffe A (2010) The role of azithromycin in patients with cystic fibrosis. Paediatr Respir Rev 11: 108114.